Literature DB >> 11390408

The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation.

C H Lee1, J H Chung.   

Abstract

hCds1 (Chk2) is an evolutionarily conserved kinase that functions in DNA damage response and cell cycle checkpoint. The Cds1 family of kinases are activated by a family of large phosphatidylinositol 3-kinase-like kinases. In humans, ataxia telangiectasia-mutated (ATM) and ataxia-telangiectasia and Rad3-related kinases activate hCds1 by phosphorylating Thr(68) . hCds1 and Cds1-related kinases contain the FHA (forkhead-associated) domain, which appears to be important for integrating the DNA damage signal. It is not known how ATM phosphorylation activates hCds1 function and whether the phosphorylation is linked to the FHA. Here, we demonstrate that the hCds1-FHA domain is essential for Thr(68) phosphorylation. Thr(68) phosphorylation, in turn, is required for ionizing radiation-induced autophosphorylation of two amino acid residues in hCds1, Thr(383) and Thr(387). These two amino acid residues, located in the activation loop of hCds1, are conserved in hCds1-related kinases and are essential for hCds1 activity. Thus, the hCds1-FHA domain mediates a chain of phosphorylation events on hCds1, which includes phosphorylation by ATM and hCds1 autophosphorylation, in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390408     DOI: 10.1074/jbc.M104414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  DNA damage checkpoint kinase Chk2 triggers replicative senescence.

Authors:  Véronique Gire; Pierre Roux; David Wynford-Thomas; Jean-Marc Brondello; Vjekoslav Dulic
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

2.  p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.

Authors:  Marina Zemskova; Michael B Lilly; Ying-Wei Lin; Jin H Song; Andrew S Kraft
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

3.  Irofulven induces replication-dependent CHK2 activation related to p53 status.

Authors:  Yutian Wang; Timothy Wiltshire; Jamie Senft; Eddie Reed; Weixin Wang
Journal:  Biochem Pharmacol       Date:  2006-10-27       Impact factor: 5.858

4.  Mechanism of Dun1 activation by Rad53 phosphorylation in Saccharomyces cerevisiae.

Authors:  Sheng-hong Chen; Marcus B Smolka; Huilin Zhou
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

5.  Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.

Authors:  Antony W Oliver; Angela Paul; Katherine J Boxall; S Elaine Barrie; G Wynne Aherne; Michelle D Garrett; Sibylle Mittnacht; Laurence H Pearl
Journal:  EMBO J       Date:  2006-06-22       Impact factor: 11.598

Review 6.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Nat Rev Mol Cell Biol       Date:  2013-09       Impact factor: 94.444

Review 7.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

8.  Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.

Authors:  Bella Kaufman; Yael Laitman; Jacek Gronwald; Robert Winqvist; Arvids Irmejs; Jan Lubinski; Katri Pylkäs; Janis Gardovskis; Edvins Miklasevics; Eitan Friedman
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

9.  Alterations of Chk1 and Chk2 expression in colon cancer.

Authors:  Magdalena Stawinska; Adam Cygankiewicz; Radzislaw Trzcinski; Michal Mik; Adam Dziki; Wanda M Krajewska
Journal:  Int J Colorectal Dis       Date:  2008-08-05       Impact factor: 2.571

10.  A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.

Authors:  Marcel A T M van Vugt; Alexandra K Gardino; Rune Linding; Gerard J Ostheimer; H Christian Reinhardt; Shao-En Ong; Chris S Tan; Hua Miao; Susan M Keezer; Jeijin Li; Tony Pawson; Timothy A Lewis; Steven A Carr; Stephen J Smerdon; Thijn R Brummelkamp; Michael B Yaffe
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.